Form 8-K - Current report:
SEC Accession No. 0001104659-20-082371
Filing Date
2020-07-09
Accepted
2020-07-09 16:12:26
Documents
14
Period of Report
2020-07-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2024388-1_8k.htm   iXBRL 8-K 30703
2 EXHIBIT 99.1 tm2024388d1_ex99-1.htm EX-99.1 28141
3 GRAPHIC tm2024388d1_ex99-1img001.jpg GRAPHIC 16882
  Complete submission text file 0001104659-20-082371.txt   261243

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcel-20200709.xsd EX-101.SCH 3174
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcel-20200709_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcel-20200709_pre.xml EX-101.PRE 22702
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2024388-1_8k_htm.xml XML 3473
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 201020609
SIC: 2836 Biological Products, (No Diagnostic Substances)